Literature DB >> 15368136

[Detection of fasciculations and other types of muscular hyperkinesias with ultrasound].

A K Scheel1, C D Reimers.   

Abstract

Muscular hyperkinesias can be visualized by means of ultrasound (US): Ultrasonographic detection of fasciculations has been best evaluated. However, so-called ripplings, myoclonias and choreatic hyperkinesias as well as tremores can also be visualized by US. Muscular US has proven as a precise imaging technique for the detection of fasciculations. Fasciculations are brief, localized muscle twitches, usually lasting for 0.2 - 0.5 seconds. Some myoklonias may present similar in US, others present with a longer duration. In addition, muscle US allows a very easy and reliable detection of tremor frequency. This article reviews the present ultrasonographic facilities in the detection of muscular hyperkinesias and gives future perspectives.

Entities:  

Mesh:

Year:  2004        PMID: 15368136     DOI: 10.1055/s-2004-813488

Source DB:  PubMed          Journal:  Ultraschall Med        ISSN: 0172-4614            Impact factor:   6.548


  4 in total

Review 1.  Ultrasound versus electromyography for the detection of fasciculation in amyotrophic lateral sclerosis: systematic review and meta-analysis.

Authors:  Márcio Luís Duarte; Wagner Iared; Acary Souza Bulle Oliveira; Lucas Ribeiro Dos Santos; Maria Stella Peccin
Journal:  Radiol Bras       Date:  2020 Mar-Apr

Review 2.  [Ultrasound of muscular diseases in children and adolescents].

Authors:  L von Rohden; Julian H W Jürgens
Journal:  Radiologe       Date:  2017-12       Impact factor: 0.635

Review 3.  Neuromuscular imaging in inherited muscle diseases.

Authors:  Mike P Wattjes; Rudolf A Kley; Dirk Fischer
Journal:  Eur Radiol       Date:  2010-04-27       Impact factor: 5.315

4.  Muscle ultrasound for early assessment of critical illness neuromyopathy in severe sepsis.

Authors:  Alexander Grimm; Ulrike Teschner; Christine Porzelius; Katrin Ludewig; Jörg Zielske; Otto W Witte; Frank M Brunkhorst; Hubertus Axer
Journal:  Crit Care       Date:  2013-10-07       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.